Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VTGN - VistaGen Therapeutics EPS misses by $0.27 beats on revenue


VTGN - VistaGen Therapeutics EPS misses by $0.27 beats on revenue

VistaGen Therapeutics (VTGN): FY GAAP EPS of -$0.49 misses by $0.27.Revenue of $1.09M beats by $0.21M.At March 31, 2021, the Company had cash and cash equivalents of approximately $103.1 million.PALISADE-1 Phase 3 trial underway to evaluate PH94B for rapid-onset acute treatment of anxiety in adults with social anxiety disorder.Shares +0.84%.Press Release

For further details see:

VistaGen Therapeutics EPS misses by $0.27, beats on revenue
Stock Information

Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com

Menu

VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...